Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    0.00 (0.00%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Upcoming Investor & Analyst Events

13 May 2024 07:00

RNS Number : 0442O
Transense Technologies PLC
13 May 2024
 

Reach - non-regulatory announcement

 

Transense Technologies plc

 ("Transense" or the "Company")

Upcoming Investor & Analyst Events

Transense Technologies, the provider of specialist sensor technology and measurement systems, announces the following investor and analyst events.

 

Monday 13 May 2024 - MelloMonday

The Company will be attending MelloMonday today, Monday 13 May, starting at 5.00pm, taking place via a Zoom Webinar. Nigel Rogers, Executive Chairman, and Ryan Maughan, Managing Director, will be presenting to webinar participants at 6.00pm, followed by a Q&A. Investors wishing to attend can register here for a free ticket. The recording will be sent out to all registrants within 48 hours of the event.

 

Wednesday 22 May 2024 - Analyst 'get to know Transense' round table

Executive Chairman, Nigel Rogers; Managing Director, Ryan Maughan; and CFO, Melvyn Segal, will be hosting the round table at 4.00pm to present the 'Transense of today', as the Group enters a pivotal point in its journey and recent operational progress brings a refreshed investment case and outlook. Analysts interested in attending should contact Transense@walbrookpr.com.

 

Tuesday 21 & Wednesday 22 May 2024 - Institutional Investor Roadshow

The Transense Directors will be in London holding institutional investor meetings on Tuesday 21 and Wednesday 22 May, hosted by Allenby Capital. 

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Stefano Aquilino/Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joesph Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:

· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and

 

· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.

 

In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKKBDPBKDQPD
Date   Source Headline
21st Sep 20167:00 amRNSFinal Results
25th Aug 20167:00 amRNSInvestor Event
16th Aug 20167:00 amRNSNotice of Results
18th Jul 20167:01 amRNSTrading Update
18th Jul 20167:00 amRNSLicence Agreement with GE
9th Mar 20162:55 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSInterim Results
16th Dec 20157:00 amRNSTranslogik Contract Win with Continental
16th Nov 20153:55 pmRNSResult of AGM
16th Nov 20157:00 amRNSAGM Statement
22nd Oct 20157:00 amRNSDirector Dealing
21st Oct 20157:00 amRNSSale of IntelliSAW Division for US$5m
8th Oct 20157:00 amRNSNotice of AGM and Posting of Accounts
28th Sep 20157:00 amRNSPreliminary unaudited results
13th Aug 20157:00 amRNSNew Translogik iTrack Contract Win
29th Jul 201512:36 pmRNSHolding(s) in Company
27th Jul 20151:30 pmRNSResult of General Meeting
27th Jul 20157:00 amRNSGM Statement & Result of Offer for Subscription
16th Jul 20157:00 amRNSRe: Open Offer
29th Jun 20157:00 amRNSPlacing and Offer for Subscription
1st May 20157:00 amRNSTranslogik Probe Used by Bosch
9th Apr 20157:00 amRNSFurther Translogik iTrack Contract Win
12th Mar 20157:00 amRNSRe Contract
9th Mar 20157:00 amRNSRe Contract
9th Mar 20157:00 amRNSHalf Yearly Report
6th Jan 20152:28 pmRNSHolding(s) in Company
30th Dec 201411:02 amRNSDirector Dealing
22nd Dec 20147:00 amRNSDirectorate Change
27th Nov 20145:42 pmRNSResult of AGM
27th Nov 20147:00 amRNSAGM Statement
20th Nov 20147:00 amRNSInitial OptiTread order for Snap-On Equipment
18th Nov 20144:46 pmRNSRelease of early warning PD detection system
28th Oct 20147:15 amRNSLaunch of 'Opti-Tread' with US partner
23rd Oct 20147:00 amRNSNotice of AGM and Posting of Accounts
23rd Sep 20141:00 pmRNSDirector Dealing
17th Sep 20147:00 amRNSPreliminary Results
16th Sep 20147:00 amRNSChange of Registered Office
8th Sep 20147:00 amRNSNotice of Results
10th Jul 201410:24 amRNSExercise of Warrants
13th Jun 20147:00 amRNSTrading Statement
4th Jun 20143:13 pmRNSExercise of Warrants and Exercise of Options
14th May 20145:30 pmRNSHolding(s) in Company
13th May 20145:30 pmRNSExercise of Warrants
30th Apr 20143:25 pmRNSExercise of Warrants
28th Mar 20145:32 pmRNSExercise of Warrants
10th Mar 20143:51 pmRNSHolding(s) in Company
7th Mar 20147:00 amRNSExercise of Warrants
3rd Mar 201411:00 amRNSHolding(s) in Company
25th Feb 20141:55 pmRNSDirector Dealing
21st Feb 201412:40 pmRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.